Peter Rosenberger Selected Research

vasodilator-stimulated phosphoprotein

1/2018	Phosphorylation of vasodilator-stimulated phosphoprotein contributes to myocardial ischemic preconditioning.
6/2011	Phosphorylation of vasodilator-stimulated phosphoprotein prevents platelet-neutrophil complex formation and dampens myocardial ischemia-reperfusion injury.
1/2011	Phosphorylation of vasodilator-stimulated phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injury.
12/2009	Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury.
8/2007	Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Rosenberger Research Topics

Disease

24	Inflammation (Inflammations) 01/2021 - 11/2003
15	Hypoxia (Hypoxemia) 01/2020 - 06/2006
10	COVID-19 11/2022 - 11/2020
10	Pneumonia (Pneumonitis) 03/2020 - 01/2010
9	Hemorrhage 01/2022 - 05/2005
9	Sepsis (Septicemia) 06/2021 - 06/2008
9	Reperfusion Injury 11/2020 - 05/2009
8	Thrombosis (Thrombus) 11/2022 - 07/2007
8	Critical Illness (Critically Ill) 01/2022 - 06/2007
8	Acute Lung Injury 04/2016 - 06/2007
6	Myocardial Ischemia (Ischemic Heart Diseases) 11/2020 - 05/2009
6	Peritonitis 01/2018 - 01/2011
6	Lung Injury 01/2017 - 04/2012
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2012
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 03/2012
4	Myocardial Infarction 07/2021 - 09/2012
4	Cardiogenic Shock 07/2021 - 08/2015
4	Infections 10/2020 - 10/2008
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2018 - 06/2004
3	Ischemia 01/2016 - 09/2014
3	Pulmonary Edema 08/2013 - 07/2005
2	Pulmonary Hypertension 01/2022 - 07/2007
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022 - 01/2015
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2020
2	Heart Failure 12/2018 - 02/2016
2	Anemia 01/2017 - 04/2013
2	Stroke (Strokes) 06/2015 - 02/2008
2	Heart Arrest (Cardiac Arrest) 02/2008 - 06/2006
2	Pulmonary Embolism 05/2005 - 09/2004
1	Air Embolism (Gas Embolism) 01/2022
1	Low Cardiac Output 07/2021
1	Septic Shock (Toxic Shock Syndrome) 06/2021
1	COVID-19 related pediatric multisystem inflammatory disease 11/2020
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 08/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2006
9	Adenosine (Adenocard)FDA LinkGeneric 04/2016 - 09/2006
8	CytokinesIBA 01/2021 - 01/2011
6	Netrin-1IBA 05/2015 - 02/2009
5	vasodilator-stimulated phosphoproteinIBA 01/2018 - 08/2007
4	Semaphorins (Semaphorin)IBA 11/2020 - 08/2012
4	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 11/2016
4	neogeninIBA 09/2014 - 04/2011
4	ZymosanIBA 09/2014 - 01/2011
4	Messenger RNA (mRNA)IBA 01/2014 - 09/2006
4	Oxygen (Dioxygen)IBA 04/2013 - 06/2006
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2012
3	NucleosidesIBA 01/2019 - 02/2009
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2016 - 07/2010
3	Transcription Factors (Transcription Factor)IBA 02/2009 - 12/2007
2	Iloprost (Ventavis)FDA Link 11/2022 - 03/2020
2	Immunoglobulin G (IgG)IBA 11/2022 - 01/2021
2	SolutionsIBA 06/2021 - 10/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2016
2	LipopolysaccharidesIBA 01/2019 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 05/2017 - 06/2015
2	pimonidazoleIBA 01/2017 - 04/2013
2	Adenosine KinaseIBA 04/2016 - 06/2008
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 09/2014
2	Aspartic Acid (Aspartate)FDA Link 01/2016 - 09/2014
2	plexinIBA 01/2016 - 09/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 06/2015
2	InterleukinsIBA 10/2014 - 11/2003
2	Small Interfering RNA (siRNA)IBA 08/2013 - 08/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 10/2008
2	ChromatinIBA 12/2007 - 08/2007
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021
1	Plasminogen Activator Inhibitor 1IBA 11/2021
1	Neutralizing AntibodiesIBA 10/2021
1	ElectrolytesIBA 06/2021
1	Crystalloid SolutionsIBA 06/2021
1	VaccinesIBA 01/2021
1	ChemokinesIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	OligonucleotidesIBA 11/2020
1	defibrotideIBA 11/2020
1	Citric Acid (Citrate)FDA LinkGeneric 10/2020

Therapy/Procedure

11	Therapeutics 07/2021 - 06/2006
10	Extracorporeal Membrane Oxygenation 01/2022 - 03/2012
6	Heart-Assist Devices 12/2018 - 08/2015
4	Ligation 11/2022 - 06/2004
4	Critical Care (Surgical Intensive Care) 10/2021 - 01/2014
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 06/2015
3	Cardiopulmonary Resuscitation (CPR) 07/2021 - 05/2006
3	Transplantation 08/2020 - 09/2012
3	Catheters 12/2019 - 08/2015
3	Embolectomy 01/2015 - 09/2004
3	Operative Surgical Procedures 01/2012 - 09/2004
2	Artificial Respiration (Mechanical Ventilation) 03/2020 - 06/2007
2	Punctures 01/2019 - 07/2010
2	Liver Transplantation 10/2014 - 09/2014
1	Neurosurgical Procedures 01/2022
1	Endovascular Aneurysm Repair 01/2022
1	Noninvasive Ventilation 07/2021
1	Renal Dialysis (Hemodialysis) 10/2020